Neurosoft Bioelectronics raises $7.5 million for stretchable brain interfaces
The Geneva start-up builds ultra-soft implants aiming for full-cortex coverage, and works with Science Corp.'s BCI platform.
Geneva-based Neurosoft Bioelectronics, an EPFL spin-off, has closed an oversubscribed $7.5 million seed round to develop stretchable, scalable brain-computer interfaces. Its ultra-soft electrodes are meant to conform to the brain and eventually cover large areas of cortex for restoring movement and speech. In February it became the first partner in Science Corp.’s BCI ecosystem program (our coverage).
Soft materials are one of the main approaches to making implants that last for years without degrading.
Learn more: Biocompatibility · Neurosoft Bioelectronics